Turning Point, the UK's leading health and social care provider, today launched a report which for the first time evaluates the economic savings available from integrating a broad range of health, housing and social care services. It finds significant evidence that integration creates efficiencies and savings, with early intervention services potentially saving the NHS up to £2.65 for every £1 spent.

More about.... New report highlights early intervention savings

The National Rheumatoid Arthritis Society (NRAS) has reported that it is delighted that the Public Accounts Committee (PAC) has endorsed the recommendations of the National Audit Office and their own recommendations for improvements to rheumatology services that will improve patient outcomes and make better use of public resources.

More about.... Improvements to rheumatology services recommended

A pilot study by UC San Diego researchers finds video games a novel treatment for symptoms of depression in elderly

More about.... Video games used to treat depression in elderly

The RCN is campaigning for guaranteed access to specialist nursing care for all patients with long term conditions

More about.... Specialist nursing care campaign

The NHS National Leadership Council has launched The Healthy NHS Board: Principles for Good Governance, highlighting the critical role boards play in ensuring that quality, centred on patient safety, effective care and patient experience, is at the heart of the NHS.

More about.... Good governance highlighted

As announced to the London Stock Exchange, Care UK, a leading health and social care provider, is to be acquired by Bridgepoint in a deal worth approximately £281 million.

More about.... Care UK deal

The UK's first integrated ‘spinning'-style fitness class is now available at The Aspire National Training Centre in Stanmore - Europe's first fully integrated leisure facility and training centre for disabled and non-disabled people.

More about.... Spinning classes for wheelchair users

The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE's provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS's successful appeal of negative NICE guidance on switching in 2007.

More about.... Frustration at NICE decision